Evaluation of six tumor markers in patients with carcinoma of unknown primary

This publication has 17 references indexed in Scilit:

• Carcinoma of unknown primary: Identification of a treatable subset?
  Annals of Oncology, 1990
• Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer
  British Journal of Cancer, 1988
• Curative Combination Chemotherapy for Patients with Advanced Poorly Differentiated Carcinoma of Unknown Primary Site
  American Journal of Clinical Oncology, 1988
• Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
  New England Journal of Medicine, 1987
• CLINICAL IMPORTANCE OF ANALYSING MALIGNANT TUMOURS OF UNCERTAIN ORIGIN WITH IMMUNOHISTOLOGICAL TECHNIQUES
  The Lancet, 1985
• Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker
  British Journal of Cancer, 1984
• Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma
  British Journal of Cancer, 1981
• Unknown primary adenocarcinoma: incidence of overinvestigation and natural history.
  BMJ, 1979
• Serum Alpha Fetoprotein and Human Chorionic Gonadotropin in the Diagnosis and Management of Nonseminomatous Germ-Cell Testicular Cancer
  New England Journal of Medicine, 1976
• Placental Proteins and Their Subunits as Tumor Markers
  Annals of Internal Medicine, 1975